Study

Treatment of Non-alcoholic Fatty Liver Disease with Curcumin: A Randomized Placebo-controlled Trial. – Cost Effective Supplements

Treatment of Non-alcoholic Fatty Liver Disease with Curcumin: A Randomized Placebo-controlled Trial.

Quick navigation


http://www.ncbi.nlm.nih.gov/pubmed/27270872


Conclusion of this study

There were also significant reductions in body mass index and serum levels of total cholesterol, low-density lipoprotein cholesterol, triglycerides, aspartate aminotransferase, alanine aminotransferase, glucose, and glycated hemoglobin compared with the placebo group. Curcumin was safe and well tolerated during the course of trial. Findings of the present proof-of-concept trial suggested improvement of different features of NAFLD after a short-term supplementation with curcumin.


Supplements analyzed in this study

Curcumin

Health conditions analyzed in this study

Liver Damage


Slightly Positive
Curcumin


Functions related to this study

Detox


Slightly Positive
Curcumin

Heart health


Slightly Positive
Curcumin


Body systems related to this study


Cardiovascular System

Digestive System
Scroll to top